Fu'an Pharmaceutical industry Investment fluorite ore extension industry chain

Fu'an Medicine (market, interrogation) (300194, Closing price of 20.95 Yuan) announced today, the company wholly owned subsidiary Chongqing Fu'an Pharmaceutical Group Qing Yu Dang Pharmacy Co., Ltd. (hereinafter referred to as Qing Yu Dang), is intended to Chongqing-Hyun Fluorite Mining Co., Ltd. (hereinafter referred to as Hyun Mining) investment 120 million yuan, for the development of the mining holding subsidiary of the Youyang County Circle Liangshan Mining Co., Ltd. fluorite Mineral Resources.　　Financial profit PO, current savings rate increase 1000% Notice that the mining area of fluorite resources Reserves evaluation value of 353 million yuan, by the parties to the transaction negotiations, the completion of the increase in capital, Fu'an Pharmaceutical subsidiary of the Yu Dang will hold a 30% stake in the mining industry, Hyun Mining shareholder Huang Huang holds 70% equity. It is worth mentioning that the current operating conditions of the mining industry is not good, as at June 30, 2013, the company's total assets of 42.269 million yuan, net assets of 14.9506 million yuan, net profit of 4.725 million yuan.　　Although the operation is not good, but the industry's shareholders Huang Huang gave a performance pledge, that is, 2014 ~2016 years, Hyun-dazzle mining accumulated net profit of no less than 90 million yuan (of which 2014 shall not be less than 20 million yuan). For the reason that the pharmaceutical company buys the mining company, the Fu'an pharmaceutical industry says that Fluorite is the main source of fluorine in industry, and the company holding subsidiary, Guang ' An, is an enterprise with the main business of producing pharmaceutical intermediates, with the ability to process fluoride production technology and related pharmaceutical intermediates,　　The company will be in the field of fluoride products and related pharmaceutical research and development, production and sales of the formation of industrial chain, to gain advantages. "Daily economic news" reporter noted that the Fu'an pharmaceutical industry with 120 million yuan won the 30%-Hyun Mining equity. While the current net assets of the mining industry is only 14.9506 million yuan, corresponding to 30% of the equity only 4.4852 million yuan, that is, a premium of 25.73 times times the acquisition, even in accordance with the value of ore reserves of 353 million yuan, the corresponding 30% of the equity is only 105.9 million yuan.